 Alexander Kaizer
Concepts (440)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 10 | 2024 | 1043 | 1.990 |
Why?
| | Bayes Theorem | 11 | 2024 | 374 | 1.830 |
Why?
| | Medical Futility | 2 | 2024 | 23 | 1.670 |
Why?
| | Models, Statistical | 5 | 2024 | 624 | 1.240 |
Why?
| | Atrioventricular Block | 4 | 2022 | 35 | 1.210 |
Why?
| | Gastroesophageal Reflux | 8 | 2024 | 232 | 1.140 |
Why?
| | Heart Rate, Fetal | 2 | 2023 | 21 | 1.010 |
Why?
| | Long QT Syndrome | 2 | 2023 | 67 | 0.930 |
Why?
| | Data Interpretation, Statistical | 3 | 2024 | 337 | 0.900 |
Why?
| | Computer Simulation | 4 | 2024 | 937 | 0.820 |
Why?
| | Laryngopharyngeal Reflux | 4 | 2024 | 15 | 0.800 |
Why?
| | Neoplasms | 5 | 2024 | 2450 | 0.790 |
Why?
| | Ritonavir | 1 | 2022 | 73 | 0.770 |
Why?
| | Bariatric Surgery | 6 | 2020 | 197 | 0.770 |
Why?
| | Weight Loss | 8 | 2023 | 738 | 0.750 |
Why?
| | Obesity, Morbid | 6 | 2020 | 242 | 0.740 |
Why?
| | Tobacco Products | 2 | 2020 | 110 | 0.740 |
Why?
| | Humans | 107 | 2025 | 129527 | 0.700 |
Why?
| | Neostigmine | 1 | 2020 | 7 | 0.670 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 245 | 0.670 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1001 | 0.630 |
Why?
| | Pediatric Obesity | 8 | 2020 | 573 | 0.630 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 28 | 0.610 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 8 | 0.600 |
Why?
| | Data Collection | 1 | 2021 | 649 | 0.600 |
Why?
| | Anaphylaxis | 1 | 2020 | 99 | 0.600 |
Why?
| | Biostatistics | 1 | 2018 | 16 | 0.580 |
Why?
| | Therapeutics | 1 | 2018 | 14 | 0.580 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 26 | 0.540 |
Why?
| | Clinical Protocols | 1 | 2018 | 253 | 0.520 |
Why?
| | Analgesics, Opioid | 7 | 2025 | 919 | 0.510 |
Why?
| | Retrospective Studies | 31 | 2025 | 14532 | 0.510 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 66 | 0.510 |
Why?
| | Fetal Diseases | 4 | 2023 | 164 | 0.510 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 237 | 0.490 |
Why?
| | Ixodidae | 1 | 2015 | 5 | 0.480 |
Why?
| | Prospective Studies | 21 | 2024 | 7150 | 0.470 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 9 | 0.460 |
Why?
| | Manometry | 7 | 2023 | 92 | 0.450 |
Why?
| | Larva | 1 | 2015 | 215 | 0.450 |
Why?
| | Treatment Outcome | 17 | 2024 | 10232 | 0.440 |
Why?
| | Pepsin A | 3 | 2023 | 19 | 0.430 |
Why?
| | Sample Size | 3 | 2024 | 116 | 0.420 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 52 | 0.400 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 15 | 0.400 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 2 | 0.390 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 23 | 0.390 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 100 | 0.370 |
Why?
| | Injections, Spinal | 3 | 2025 | 105 | 0.370 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 235 | 0.360 |
Why?
| | Female | 48 | 2025 | 68650 | 0.360 |
Why?
| | Information Dissemination | 2 | 2024 | 204 | 0.360 |
Why?
| | Obesity | 5 | 2023 | 2875 | 0.360 |
Why?
| | Nerve Block | 3 | 2021 | 69 | 0.350 |
Why?
| | Anesthetics | 2 | 2022 | 75 | 0.340 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2022 | 1368 | 0.340 |
Why?
| | Pain Management | 2 | 2025 | 330 | 0.330 |
Why?
| | Body Contouring | 2 | 2020 | 8 | 0.330 |
Why?
| | Adult | 30 | 2025 | 35505 | 0.330 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 30 | 0.320 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 13 | 0.320 |
Why?
| | Esophagus | 2 | 2020 | 250 | 0.290 |
Why?
| | Pregnancy | 8 | 2023 | 6412 | 0.280 |
Why?
| | Surgeons | 2 | 2021 | 264 | 0.280 |
Why?
| | Male | 40 | 2025 | 63586 | 0.280 |
Why?
| | Probability | 3 | 2022 | 302 | 0.270 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2024 | 21 | 0.270 |
Why?
| | Pain, Postoperative | 5 | 2022 | 244 | 0.270 |
Why?
| | Anesthetics, Local | 3 | 2022 | 79 | 0.260 |
Why?
| | Nicotine | 2 | 2020 | 304 | 0.260 |
Why?
| | Cough | 2 | 2024 | 117 | 0.240 |
Why?
| | Child | 18 | 2024 | 20932 | 0.240 |
Why?
| | Fractures, Multiple | 1 | 2025 | 4 | 0.240 |
Why?
| | Bupivacaine | 2 | 2022 | 31 | 0.240 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 391 | 0.230 |
Why?
| | Hearing Aids | 2 | 2023 | 73 | 0.230 |
Why?
| | Cancer Pain | 1 | 2025 | 27 | 0.230 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2024 | 13 | 0.230 |
Why?
| | Incidence | 6 | 2023 | 2643 | 0.230 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 374 | 0.230 |
Why?
| | Laparoscopy | 2 | 2020 | 446 | 0.220 |
Why?
| | Blood Transfusion | 2 | 2024 | 298 | 0.220 |
Why?
| | Body Weight | 2 | 2019 | 941 | 0.220 |
Why?
| | Biometry | 1 | 2024 | 69 | 0.220 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 320 | 0.220 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2024 | 21 | 0.220 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 5 | 0.220 |
Why?
| | Myotomy | 1 | 2023 | 11 | 0.210 |
Why?
| | Atrial Flutter | 1 | 2023 | 35 | 0.210 |
Why?
| | Heart Arrest | 2 | 2024 | 323 | 0.210 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 44 | 0.210 |
Why?
| | Predictive Value of Tests | 3 | 2024 | 1950 | 0.200 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 56 | 0.200 |
Why?
| | Intestinal Atresia | 1 | 2023 | 14 | 0.200 |
Why?
| | Vitamin D Deficiency | 1 | 2025 | 177 | 0.200 |
Why?
| | Aged | 16 | 2025 | 22063 | 0.200 |
Why?
| | Point-of-Care Systems | 1 | 2024 | 149 | 0.200 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 28 | 0.200 |
Why?
| | Lopinavir | 1 | 2022 | 30 | 0.200 |
Why?
| | Lidocaine | 1 | 2023 | 41 | 0.200 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.200 |
Why?
| | Neutropenia | 1 | 2023 | 137 | 0.200 |
Why?
| | Triage | 1 | 2024 | 206 | 0.200 |
Why?
| | Middle Aged | 18 | 2025 | 31087 | 0.190 |
Why?
| | Fetal Heart | 2 | 2019 | 55 | 0.190 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 12 | 0.190 |
Why?
| | Electromyography | 1 | 2024 | 379 | 0.190 |
Why?
| | Infant | 7 | 2025 | 9005 | 0.190 |
Why?
| | Tremor | 1 | 2022 | 60 | 0.190 |
Why?
| | Tympanoplasty | 1 | 2022 | 7 | 0.190 |
Why?
| | Lung | 3 | 2024 | 3928 | 0.190 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 15 | 0.190 |
Why?
| | Diaphragm | 2 | 2022 | 42 | 0.190 |
Why?
| | Postoperative Complications | 4 | 2021 | 2475 | 0.190 |
Why?
| | Deafness | 1 | 2023 | 79 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 55 | 0.190 |
Why?
| | Telemedicine | 2 | 2021 | 792 | 0.190 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2021 | 19 | 0.190 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 6 | 0.190 |
Why?
| | Funnel Chest | 1 | 2021 | 25 | 0.190 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 59 | 0.180 |
Why?
| | Vitamin D | 1 | 2025 | 379 | 0.180 |
Why?
| | Psychological Trauma | 1 | 2022 | 54 | 0.180 |
Why?
| | Nose Neoplasms | 1 | 2021 | 20 | 0.180 |
Why?
| | Hepatectomy | 1 | 2023 | 212 | 0.180 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 23 | 0.180 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.180 |
Why?
| | Disabled Persons | 1 | 2023 | 138 | 0.180 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 63 | 0.180 |
Why?
| | Patient Handoff | 1 | 2021 | 32 | 0.180 |
Why?
| | Medicare Part D | 1 | 2021 | 25 | 0.180 |
Why?
| | Tumor Burden | 1 | 2022 | 287 | 0.180 |
Why?
| | Prostate | 1 | 2022 | 170 | 0.180 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 32 | 0.180 |
Why?
| | Fetus | 2 | 2023 | 780 | 0.180 |
Why?
| | Adolescent | 17 | 2023 | 20409 | 0.180 |
Why?
| | Risk Factors | 11 | 2025 | 9779 | 0.180 |
Why?
| | Congenital Microtia | 1 | 2020 | 4 | 0.180 |
Why?
| | Specialties, Surgical | 1 | 2022 | 71 | 0.180 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 195 | 0.180 |
Why?
| | Cystectomy | 1 | 2021 | 37 | 0.180 |
Why?
| | Ear | 1 | 2020 | 31 | 0.170 |
Why?
| | Infant, Newborn | 5 | 2023 | 5769 | 0.170 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 195 | 0.170 |
Why?
| | Bias | 1 | 2021 | 196 | 0.170 |
Why?
| | Shock | 1 | 2021 | 92 | 0.170 |
Why?
| | Prevalence | 3 | 2023 | 2561 | 0.170 |
Why?
| | Electrocardiography | 1 | 2023 | 612 | 0.170 |
Why?
| | Ocular Hypertension | 1 | 2021 | 67 | 0.170 |
Why?
| | Drug Costs | 1 | 2021 | 100 | 0.170 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 1997 | 0.170 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 76 | 0.170 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 79 | 0.170 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.160 |
Why?
| | Hearing Loss | 1 | 2023 | 209 | 0.160 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 104 | 0.160 |
Why?
| | Carcinoma | 1 | 2021 | 213 | 0.160 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 102 | 0.160 |
Why?
| | Exercise | 3 | 2020 | 1931 | 0.160 |
Why?
| | Speech Perception | 1 | 2021 | 83 | 0.160 |
Why?
| | Tracheostomy | 1 | 2021 | 129 | 0.160 |
Why?
| | Hyperplasia | 1 | 2020 | 175 | 0.160 |
Why?
| | Anesthesia | 1 | 2022 | 172 | 0.160 |
Why?
| | Spine | 1 | 2021 | 160 | 0.160 |
Why?
| | Stillbirth | 1 | 2019 | 60 | 0.160 |
Why?
| | Enteral Nutrition | 1 | 2021 | 186 | 0.160 |
Why?
| | Drug Prescriptions | 1 | 2021 | 242 | 0.160 |
Why?
| | Cochlear Implantation | 1 | 2021 | 88 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.150 |
Why?
| | Cochlear Implants | 1 | 2021 | 104 | 0.150 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 58 | 0.150 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 88 | 0.150 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 225 | 0.150 |
Why?
| | Medically Underserved Area | 1 | 2019 | 84 | 0.150 |
Why?
| | Cardiotocography | 1 | 2018 | 3 | 0.150 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 100 | 0.150 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 10 | 0.150 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 68 | 0.150 |
Why?
| | Outpatients | 1 | 2022 | 375 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 367 | 0.150 |
Why?
| | Perioperative Care | 1 | 2020 | 165 | 0.150 |
Why?
| | Baths | 1 | 2018 | 15 | 0.150 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.150 |
Why?
| | Depressive Disorder, Major | 1 | 2022 | 344 | 0.150 |
Why?
| | Genotype | 1 | 2023 | 1827 | 0.150 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4073 | 0.150 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 12 | 0.150 |
Why?
| | Nutritional Status | 1 | 2021 | 328 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 509 | 0.150 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 41 | 0.150 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2018 | 20 | 0.150 |
Why?
| | Africa, Western | 1 | 2018 | 17 | 0.150 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1708 | 0.140 |
Why?
| | Cannabinoids | 1 | 2020 | 154 | 0.140 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5078 | 0.140 |
Why?
| | Gastroenterology | 1 | 2020 | 177 | 0.140 |
Why?
| | Glaucoma | 1 | 2021 | 221 | 0.140 |
Why?
| | Phenotype | 2 | 2023 | 3058 | 0.140 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 35 | 0.140 |
Why?
| | Body Mass Index | 4 | 2023 | 2269 | 0.140 |
Why?
| | Barrett Esophagus | 1 | 2020 | 148 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 275 | 0.140 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 43 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 121 | 0.140 |
Why?
| | Dyslipidemias | 1 | 2019 | 173 | 0.140 |
Why?
| | Penicillin Resistance | 1 | 2017 | 8 | 0.140 |
Why?
| | Serogroup | 1 | 2017 | 34 | 0.140 |
Why?
| | Disinfection | 1 | 2018 | 117 | 0.130 |
Why?
| | Child Behavior | 1 | 2019 | 235 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 482 | 0.130 |
Why?
| | Phentermine | 1 | 2016 | 9 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 158 | 0.130 |
Why?
| | Burns | 1 | 2021 | 292 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2021 | 615 | 0.130 |
Why?
| | Parkinson Disease | 1 | 2022 | 462 | 0.130 |
Why?
| | Swine | 3 | 2024 | 760 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2018 | 91 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 635 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 219 | 0.130 |
Why?
| | Blood Platelets | 1 | 2019 | 386 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2022 | 719 | 0.130 |
Why?
| | Fructose | 1 | 2016 | 105 | 0.130 |
Why?
| | Spinal Cord | 3 | 2024 | 352 | 0.130 |
Why?
| | Gestational Age | 4 | 2019 | 875 | 0.130 |
Why?
| | Pneumonectomy | 1 | 2017 | 151 | 0.130 |
Why?
| | United States | 9 | 2024 | 13865 | 0.130 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 538 | 0.120 |
Why?
| | Internal Medicine | 1 | 2018 | 245 | 0.120 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 112 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2022 | 722 | 0.120 |
Why?
| | Body Composition | 1 | 2019 | 649 | 0.120 |
Why?
| | Mentoring | 1 | 2018 | 132 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3081 | 0.120 |
Why?
| | Adiposity | 2 | 2019 | 504 | 0.120 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 221 | 0.120 |
Why?
| | Missouri | 1 | 2015 | 61 | 0.120 |
Why?
| | Pain Measurement | 3 | 2025 | 507 | 0.120 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 161 | 0.120 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 282 | 0.120 |
Why?
| | Suicide | 1 | 2022 | 613 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2018 | 268 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 741 | 0.120 |
Why?
| | Meals | 1 | 2016 | 119 | 0.120 |
Why?
| | Precision Medicine | 1 | 2019 | 385 | 0.120 |
Why?
| | Critical Illness | 1 | 2021 | 758 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 577 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2022 | 711 | 0.120 |
Why?
| | Forests | 1 | 2015 | 58 | 0.120 |
Why?
| | Length of Stay | 4 | 2021 | 1132 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 347 | 0.110 |
Why?
| | Disease Outbreaks | 1 | 2018 | 349 | 0.110 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 5429 | 0.110 |
Why?
| | Pilot Projects | 4 | 2021 | 1594 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 812 | 0.110 |
Why?
| | Veterans | 2 | 2022 | 1382 | 0.110 |
Why?
| | Pregnancy Complications | 1 | 2018 | 493 | 0.110 |
Why?
| | Feeding Behavior | 1 | 2019 | 625 | 0.110 |
Why?
| | Quality of Life | 1 | 2025 | 2694 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 484 | 0.100 |
Why?
| | Cannabis | 1 | 2020 | 461 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 895 | 0.100 |
Why?
| | Mothers | 1 | 2019 | 731 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1235 | 0.100 |
Why?
| | Medicare | 3 | 2024 | 716 | 0.100 |
Why?
| | Clinical Competence | 1 | 2020 | 1015 | 0.100 |
Why?
| | Hypoxia | 1 | 2020 | 1081 | 0.100 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 50 | 0.100 |
Why?
| | Animals | 5 | 2024 | 35334 | 0.100 |
Why?
| | Muscle Spasticity | 2 | 2023 | 58 | 0.100 |
Why?
| | Minnesota | 3 | 2018 | 149 | 0.100 |
Why?
| | Seasons | 1 | 2015 | 492 | 0.100 |
Why?
| | Physicians | 1 | 2021 | 872 | 0.100 |
Why?
| | Hospitalization | 1 | 2022 | 2076 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 796 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1049 | 0.100 |
Why?
| | Electric Impedance | 2 | 2023 | 102 | 0.090 |
Why?
| | Intensive Care Units | 3 | 2021 | 737 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1168 | 0.090 |
Why?
| | Mental Health | 1 | 2018 | 687 | 0.090 |
Why?
| | Child, Preschool | 6 | 2025 | 10499 | 0.090 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1125 | 0.090 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 83 | 0.090 |
Why?
| | ROC Curve | 2 | 2024 | 503 | 0.090 |
Why?
| | Anxiety | 1 | 2018 | 976 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2044 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 539 | 0.090 |
Why?
| | Cohort Studies | 4 | 2021 | 5423 | 0.090 |
Why?
| | Saliva | 2 | 2023 | 212 | 0.090 |
Why?
| | Operating Rooms | 2 | 2022 | 116 | 0.080 |
Why?
| | Ecosystem | 1 | 2015 | 561 | 0.080 |
Why?
| | Cesarean Section | 2 | 2023 | 183 | 0.080 |
Why?
| | Medical Oncology | 2 | 2022 | 267 | 0.080 |
Why?
| | Operative Time | 2 | 2022 | 123 | 0.080 |
Why?
| | Time Factors | 4 | 2022 | 6530 | 0.080 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 153 | 0.080 |
Why?
| | Depression | 1 | 2018 | 1321 | 0.080 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 130 | 0.080 |
Why?
| | Prognosis | 3 | 2023 | 3772 | 0.080 |
Why?
| | Hemodynamics | 2 | 2024 | 1094 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2342 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1842 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4891 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 869 | 0.060 |
Why?
| | Algorithms | 2 | 2024 | 1614 | 0.060 |
Why?
| | Mice | 1 | 2022 | 16973 | 0.060 |
Why?
| | Caregivers | 2 | 2023 | 807 | 0.060 |
Why?
| | Decompression | 1 | 2024 | 3 | 0.060 |
Why?
| | False Negative Reactions | 1 | 2024 | 52 | 0.060 |
Why?
| | Disease Progression | 2 | 2024 | 2628 | 0.060 |
Why?
| | Monitoring, Intraoperative | 1 | 2024 | 51 | 0.060 |
Why?
| | Quality Control | 1 | 2024 | 161 | 0.050 |
Why?
| | Ventricular Fibrillation | 1 | 2024 | 57 | 0.050 |
Why?
| | Neck | 1 | 2024 | 95 | 0.050 |
Why?
| | Patient Positioning | 1 | 2024 | 54 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2024 | 29 | 0.050 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 28 | 0.050 |
Why?
| | Larynx | 1 | 2024 | 59 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2024 | 60 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 12 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 57 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1500 | 0.050 |
Why?
| | Epinephrine | 1 | 2023 | 141 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3383 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 112 | 0.050 |
Why?
| | Edema | 1 | 2023 | 124 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2724 | 0.050 |
Why?
| | Coronary Artery Bypass | 1 | 2024 | 224 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 86 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2503 | 0.050 |
Why?
| | Rotator Cuff | 1 | 2022 | 46 | 0.050 |
Why?
| | Goals | 1 | 2023 | 163 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 6 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 114 | 0.050 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.050 |
Why?
| | Patients | 1 | 2023 | 169 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 170 | 0.050 |
Why?
| | Motor Skills | 1 | 2022 | 95 | 0.050 |
Why?
| | Malawi | 1 | 2021 | 49 | 0.050 |
Why?
| | Prostheses and Implants | 1 | 2022 | 132 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2023 | 204 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 483 | 0.040 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 89 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 708 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 169 | 0.040 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 25 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 60 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 175 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 9 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 242 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3255 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.040 |
Why?
| | Noise | 1 | 2021 | 67 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 2 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 63 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 7 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 542 | 0.040 |
Why?
| | Iron | 1 | 2022 | 283 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 71 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 138 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 7 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 53 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 18 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 436 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 680 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 3968 | 0.040 |
Why?
| | Child Abuse | 1 | 2025 | 513 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4403 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 200 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 26 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 50 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 402 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 583 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 299 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 84 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 13 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 270 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 123 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 194 | 0.040 |
Why?
| | Patient Care Bundles | 1 | 2018 | 20 | 0.040 |
Why?
| | Chlorhexidine | 1 | 2018 | 23 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 763 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 160 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2018 | 84 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2020 | 261 | 0.040 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 14 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 306 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2018 | 51 | 0.040 |
Why?
| | Staff Development | 1 | 2018 | 55 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 122 | 0.040 |
Why?
| | Carrier State | 1 | 2018 | 60 | 0.040 |
Why?
| | Catheters | 1 | 2018 | 70 | 0.040 |
Why?
| | Chronic Disease | 1 | 2024 | 1722 | 0.040 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 218 | 0.040 |
Why?
| | Comorbidity | 1 | 2022 | 1548 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 12438 | 0.030 |
Why?
| | Endoscopy | 1 | 2020 | 290 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 636 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 278 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 329 | 0.030 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 18 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 178 | 0.030 |
Why?
| | Africa | 1 | 2017 | 99 | 0.030 |
Why?
| | Risk | 1 | 2019 | 857 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 321 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 566 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 53 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2021 | 851 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1311 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1211 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 87 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 504 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 337 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 348 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 896 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 518 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 317 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 246 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 103 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 252 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1261 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 209 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1870 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1836 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2016 | 241 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 549 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 1918 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 391 | 0.030 |
Why?
| | Registries | 1 | 2021 | 1902 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1983 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 1103 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1636 | 0.020 |
Why?
| | Primary Health Care | 1 | 2023 | 1677 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 897 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2016 | 1873 | 0.020 |
Why?
| | Parents | 1 | 2019 | 1309 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1211 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2313 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|